KAT2A and neoplasm: We also noted that although pharmaceutical GCN5 inhibition shows potent effect alone or in combination with CDK2 inhibition, it is currently unsuitable for in vivo use as the toxicity was strong (data not shown) and that’s the reason we used genetic silencing in animal models for xenograft tumor.